/u/WalkingHorse's posts in /r/LungCancerSupport

Year:

Only show posts with narrations

Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer | Cancer Epidemiology, Biomarkers & Prevention

1 upvotes

Mark as read: Add to a list

Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period

1 upvotes

Mark as read: Add to a list

Aspergillus fumigatus Is Dual-Tracer 18FDG/68Ga-FAPI PET/CT Capable of Distinguishing Fungal Infection and Unspecific Inflammation From Recurrent Lung Cancer?

1 upvotes

Mark as read: Add to a list

FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism | Journal of Experimental & Clinical Cancer Research

1 upvotes

Mark as read: Add to a list

A case of organizing pneumonia in rearranged during transfection fusion-positive lung adenocarcinoma treated with selpercatinib

1 upvotes

Mark as read: Add to a list

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth

1 upvotes

Mark as read: Add to a list

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer

1 upvotes

Mark as read: Add to a list

Long-term outcome of definitive radiotherapy for locally advanced non-small cell lung cancer: A real-world single-center study in the pre-durvalumab era

1 upvotes

Mark as read: Add to a list

Frontiers | Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer

1 upvotes

Mark as read: Add to a list

Frontiers | Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study

1 upvotes

Mark as read: Add to a list

Title	Upvotes	Mark as read	Favorited	Rating	Add to a list
Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer \| Cancer Epidemiology, Biomarkers & Prevention	1
Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period	1
Aspergillus fumigatus Is Dual-Tracer 18FDG/68Ga-FAPI PET/CT Capable of Distinguishing Fungal Infection and Unspecific Inflammation From Recurrent Lung Cancer?	1
FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism \| Journal of Experimental & Clinical Cancer Research	1
A case of organizing pneumonia in rearranged during transfection fusion-positive lung adenocarcinoma treated with selpercatinib	1
Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth	1
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer	1
Long-term outcome of definitive radiotherapy for locally advanced non-small cell lung cancer: A real-world single-center study in the pre-durvalumab era	1
Frontiers \| Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer	1
Frontiers \| Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study	1